MedTrace Logo

The Prognostic Value of Tertiary Lymphatic Structure in Esophageal Squamous Cell Carcinoma

NCT06241066 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 359

Last updated 2024-02-05

No results posted yet for this study

Summary

Retrospective analysis of the presence and maturity of tertiary lymphoid structures in pathological sections of patients with esophageal squamous cell carcinoma after surgical treatment. Pay attention to the overall survival and disease free survival of these esophageal squamous cell carcinoma patients.

Conditions

Interventions

OTHER

no-Intervention

no-Intervention

Sponsors & Collaborators

  • Tianjin Medical University Cancer Institute and Hospital

    lead OTHER

Principal Investigators

  • Wencheng Zhang, M.D. · Tianjin Medical University Cancer Institute and Hospital

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-01
Primary Completion
2023-10-31
Completion
2023-10-31

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06241066 on ClinicalTrials.gov